A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia

Clinical trial NCT01635296 · COMPLETED

Trial details

NCT number: NCT01635296
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Myelogenous Leukemia, Acute

Start date: 2012-07-01
Primary completion: 2013-10-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.